Vaccines Products

Highlight

• First Covid-19 inhaled vaccine
• Triple immunity: cellular, humoral and mucosal
• No injection - easy vaccination, reduce-needle-stick risk
• Good safety, no injection-site adverse events

Indication

Prevention of COVID-19 caused by SARS-CoV-2 in adults 18 years and older.

Specification:

• Form:Solution for injection & solution for inhalation
• Strength:0.5 mL IM · 0.1 mL inhalation per dose
• Pack:Box, 1 Vial
• REG. BPOM:IM: DKI2360300443A1 · Inhalation: DKI2360300568A1
• Halal:✓ Halal-certified
• Note:Produced on demand

Highlight

• WHO Pre-qualified
• Porcine Free
• Fast-acting and Long-lasting protection
• Extesive use in more than 20 countries
• Well-tolerated Few adverse reactions

Indication

Hepatitis A Vaccine for Children 1 Year – 15 Year, Hepatitis A Vaccine for adult > 16 years.

Specification:

• Form:Suspension for injection in a prefilled syringe or vial
• Strength:Pediatric 0.5 mL · Adult 1.0 mL
• Pack:1 PFS or 1 Vial @ 0.5 mL · 1 PFS or 1 Vial @ 1.0 mL
• REG. BPOM:DKI2257300243A1 · A2 · B1 · B2
• Halal:N/A (Porcine-free)
• Approvals:WHO Pre-qualified · 20+ countries

Highlight

• The 1st mRNA Vaccine produced locally in Indonesia
• The 1st Halal mRNA Vaccine

Indication

For active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals 18 years of age and older.

Specification:

• Form:Injection
• Strength:0.15 mL / dose
• Pack:Box, 1 Vial @ 0.3 mL
• REG. BPOM:DKL2557902043A1
• Halal:✓ 1st Halal mRNA vaccine
• Note:Produced on demand

Highlight

• 3rd MCV4 in the world
• Conjugated vaccine with robust immunogenicity profile and provides longer protection results
• High Quality
• Menhycia has been received Halal Decree & Certificate by MUI

Indication

Active immunization against invasive meningococcal disease caused by Neisseria meningitidis serogroups A,C,Y and W.

Specification:

• Form:Powder & solution for IM injection
• Strength:0.5 mL / dose (1 dose)
• Pack:Box, 1 Vial powder + 1 Vial solution @ 0.5 mL
• REG. BPOM:DKI2460300644A1
• Halal:✓ Halal Decree & Certificate by BPJPH
• Approvals:3rd MCV4 in the world

Highlight

• 1st PCV-13 locally manufactured in Indonesia
• Halal Decree & Certificate by BPJPH
• Clinically proven through local clinical trials

Indication

Prevention of invasive disease caused by 13 pneumococcal serotypes; indicated for use in infants and children 6 weeks through 5 years of age.

Specification:

• Form: -
• Strength: -
• Pack: -
• REG. BPOM: -
• BPJS: -

Highlight

• WHO Pre-qualifiedWHO Pre-qualified
• High Quality
• Persistent protection against infection of HPV types 16 and 18

Indication

Prevent cervical cancer, cervical intraepithelial neoplasia (CIN) grade 2 or grade 3, and cervical adenocarcinoma in situ (AIS) caused by high-risk HPV types 16 and 18 in females 9 through 30 years of age.

Specification:

• Form:Suspension for injection in a prefilled syringe or vial
• Strength:0.5 mL / dose
• Pack:Box, 1 Vial @ 0.5 mL · Box, 1 PFS @ 0.5 mL
• REG. BPOM:DKI2442900443A1 · A2
• Halal:✓ Halal-certified
• Approvals:WHO Pre-qualified

Highlight

• 1st PCV 13 Local manufactured In Indonesia
• Valenina has been received Halal Decree & Certificate by MUI
• Valenina has been approved for Local Clinical Trial

Indication

Pneumococal Conjugate Vaccine prevent invasive disease caused by 13 serotypes.

Specification:

• Form:Suspension for injection in a prefilled syringe or vial
• Strength:0.5 mL / dose
• Pack:Box of 20 vials @ 0.5 mL · Box, 1 PFS @ 0.5 mL
• REG. BPOM:DKL2457901643A1 · A2 · DKI2342900343A1 · A2
• Halal:✓ Halal Decree & Certificate by BPJPH
• Approvals:1st PCV-13 locally manufactured · Clinically proven through local clinical trials